Mudassir Meraj Banday, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas | 1 | 2022 | 124 | 0.800 |
Why?
|
| Lung Transplantation | 4 | 2024 | 1309 | 0.680 |
Why?
|
| Primary Graft Dysfunction | 1 | 2021 | 112 | 0.680 |
Why?
|
| Arthritis, Psoriatic | 1 | 2022 | 219 | 0.660 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 1049 | 0.540 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 757 | 0.510 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2892 | 0.360 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 11928 | 0.210 |
Why?
|
| Parasites | 1 | 2023 | 160 | 0.180 |
Why?
|
| Interferon Type I | 1 | 2023 | 569 | 0.160 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2024 | 1361 | 0.150 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2023 | 521 | 0.140 |
Why?
|
| Virus Diseases | 1 | 2023 | 724 | 0.140 |
Why?
|
| Osteogenesis | 1 | 2023 | 1288 | 0.130 |
Why?
|
| Autoantibodies | 1 | 2024 | 2121 | 0.130 |
Why?
|
| Malaria, Falciparum | 1 | 2023 | 1077 | 0.120 |
Why?
|
| Lung | 3 | 2023 | 10099 | 0.120 |
Why?
|
| Autophagy | 1 | 2022 | 1349 | 0.120 |
Why?
|
| Glutaredoxins | 1 | 2013 | 32 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 998 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2021 | 2937 | 0.110 |
Why?
|
| Metabolome | 1 | 2020 | 1009 | 0.100 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2023 | 1672 | 0.100 |
Why?
|
| Tyrosine-tRNA Ligase | 1 | 2011 | 10 | 0.100 |
Why?
|
| Cystic Fibrosis | 1 | 2021 | 1294 | 0.090 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2019 | 1613 | 0.090 |
Why?
|
| Plasmodium falciparum | 2 | 2023 | 1741 | 0.080 |
Why?
|
| Kidney Transplantation | 1 | 2024 | 4262 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 2909 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2021 | 3703 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2021 | 9384 | 0.060 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2024 | 153 | 0.060 |
Why?
|
| Lysophospholipase | 1 | 2023 | 66 | 0.050 |
Why?
|
| Histocompatibility Testing | 1 | 2024 | 716 | 0.050 |
Why?
|
| Malaria | 1 | 2011 | 1249 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 39348 | 0.040 |
Why?
|
| HLA Antigens | 1 | 2024 | 1334 | 0.040 |
Why?
|
| Erythrocytes | 2 | 2023 | 2418 | 0.040 |
Why?
|
| Hydrogels | 1 | 2023 | 744 | 0.040 |
Why?
|
| Protozoan Proteins | 1 | 2023 | 843 | 0.030 |
Why?
|
| Humans | 10 | 2024 | 768166 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 11101 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 2014 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2021 | 81762 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2023 | 1812 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2023 | 1893 | 0.030 |
Why?
|
| Middle Aged | 3 | 2024 | 223492 | 0.030 |
Why?
|
| Sulfhydryl Compounds | 1 | 2013 | 296 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2024 | 3589 | 0.020 |
Why?
|
| Oxygen | 1 | 2023 | 4270 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2013 | 699 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 1752 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2024 | 4492 | 0.020 |
Why?
|
| Glutathione | 1 | 2013 | 589 | 0.020 |
Why?
|
| Male | 4 | 2024 | 364719 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2023 | 3073 | 0.020 |
Why?
|
| Neutrophils | 1 | 2023 | 3786 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2013 | 2179 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 1951 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 4912 | 0.020 |
Why?
|
| Female | 3 | 2024 | 397192 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 10101 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12840 | 0.020 |
Why?
|
| Disease Progression | 1 | 2023 | 13671 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 12543 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 3956 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2023 | 11669 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 7608 | 0.020 |
Why?
|
| Binding Sites | 1 | 2013 | 6020 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 5027 | 0.010 |
Why?
|
| Age Factors | 1 | 2021 | 18412 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2013 | 5403 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 8647 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 17140 | 0.010 |
Why?
|
| Animals | 3 | 2023 | 169246 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 13421 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2011 | 3228 | 0.010 |
Why?
|
| Protein Binding | 1 | 2013 | 9343 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 17622 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 4352 | 0.010 |
Why?
|
| Aged | 2 | 2024 | 171504 | 0.010 |
Why?
|
| Mice | 2 | 2019 | 82029 | 0.010 |
Why?
|
| Adult | 2 | 2024 | 223646 | 0.010 |
Why?
|
| Cell Line | 1 | 2011 | 15597 | 0.010 |
Why?
|
| Macrophages | 1 | 2011 | 5799 | 0.010 |
Why?
|
| Cytokines | 1 | 2011 | 7453 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2011 | 19015 | 0.010 |
Why?
|
| Young Adult | 1 | 2021 | 60066 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 89169 | 0.010 |
Why?
|